Methyl 1-(1-benzyl-1H-pyrazol-4-yl)-1H-indole-3-carboxylate

Catalog No. :
ACMEZY149
CAS No. :
2007920-31-0
Molecular Formula :
C20H17N3O2
Molecular Weight :
331.38

IUPAC Name:methyl 1-(1-benzyl-1H-pyrazol-4-yl)-1H-indole-3-carboxylate

Methyl 1-(1-benzyl-1H-pyrazol-4-yl)-1H-indole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$1039.00Login to see priceInquiryInquiry
1g97%$2586.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(1-benzyl-1H-pyrazol-4-yl)-1H-indole-3-carboxylate
IUPAC Namemethyl 1-(1-benzyl-1H-pyrazol-4-yl)-1H-indole-3-carboxylate
MDL No.MFCD30471929
Molecular FormulaC20H17N3O2
Molecular Weight331.38
SMILESO=C(C1=CN(C2=CN(CC3=CC=CC=C3)N=C2)C4=C1C=CC=C4)OC
InChI KeyHGPLBEINNSLPAC-UHFFFAOYSA-N
SynonymMethyl 1-(1-benzyl-1H-pyrazol-4-yl)-1h-indole-3-carboxylate;1H-Indole-3-carboxylic acid, 1-[1-(phenylmethyl)-1H-pyrazol-4-yl]-, methyl ester
CAS No.2007920-31-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMEZY149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGOTW052 route compound structure diagram
    ACGOTW05250877-41-3 In Stock
  2. Plus
  3. ACUSRG743 route compound structure diagram
    ACUSRG743942-24-5 In Stock
  4. Then
  5. ACMEZY149 route product structure diagram
    ACMEZY1492007920-31-0
Inquiry

2. ACMEZY149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUSRG743 route compound structure diagram
    ACUSRG743942-24-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMEZY149 route product structure diagram
    ACMEZY1492007920-31-0
Inquiry

Comments (0)